Michalina Kosowska

Michalina Kosowska

Auto-generated profile, based on publicly available information

Michalina Kosowska

Military Institute of Medicine – National Research Institute, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
SKSebastian Kupisiak
Sebastian Kupisiak
ARAneta Rostkowska
Aneta Rostkowska
MDMalwina Draim
Malwina Draim
NPNatalia Pasierb
Natalia Pasierb
MKMichalina Kosowska
Michalina Kosowska
KTKacper Trząsalski
Kacper Trząsalski
Introduction and Purpose: Myopia is currently the most prevalent refractive error worldwide, with a rapidly increasing incidence, particularly among children and adolescents in urbanized regions. This review outlines the most effective evidence-based strategies for preventing and slowing the progression of myopia, with a focus on both pharmacological and non-pharmacological approaches. The State of Knowledge: Recent studies have highlighted that increased time spent outdoors significantly reduces the onset of myopia in non-myopic children, though its effect on progression in already myopic individuals appears limited. Light exposure, especially to moderate-intensity natural light, has shown potential in mitigating axial elongation and promoting choroidal thickening. Sleep quality and duration may also influence myopia development, though further research is needed to confirm this relationship. Pharmacological intervention with low-dose atropine (particularly 0.01–0.05%) is currently the most effective and widely accepted treatment, offering substantial benefits with minimal side effects. Optical interventions such as orthokeratology, multifocal spectacle lenses, and dual-focus contact lenses have demonstrated efficacy in controlling axial elongation by modifying peripheral retinal defocus. Summary: Combining lifestyle modifications (outdoor activity and light exposure) with pharmacological (low-dose atropine) and optical (e.g., orthokeratology and bifocal lenses) interventions provides a comprehensive, multimodal strategy to manage and slow myopia progression. Early implementation of such interventions is essential in addressing the growing public health burden of myopia.

3 January 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
NDNatalia Domańska
Natalia Domańska
MBMałgorzata Bojarska
Małgorzata Bojarska
JBJulia Bogucka
Julia Bogucka
ABAnna Brzyska
Anna Brzyska
MKMichalina Kosowska
Michalina Kosowska
HPHalina Piecewicz-Szczęsna
Halina Piecewicz-Szczęsna
Introduction: Epilepsy is a chronic, non-infectious and one of the most common neurological disease. About 70 million people worldwide suffer from it and these are patients of all ages. Despite the existence of many anticonvulsants and multiple lines of treatment, some patients still experience symptoms of the epilepsy. International league against epilepsy says that one-third of people with epilepsy fail to control it with anti-epileptic drugs (AED) and continue to have seizures. Purpose: The aim of the study is to analyze the impact of using a ketogenic diet in patients with epilepsy that meets the criteria for drug-resistant epilepsy. Materials and method: In April 2024, articles found in the Medline (Pubmed) databases were selected by using the following keywords: ketogenic diet in drug-resistant epilepsy, drug-resistant epilepsy, ketogenic diet and selected articles from 2018-2023. Conclusions: In the ketogenic diet, ketones formed from the oxidation of fatty acids are the source of energy instead of glucose. Ketones increase the amount of inhibitory neurotransmitters and glutathione. It improves neuronal hemostasis and increases cells’ resistance during excessive electrical discharges in the brain. These qualities are responsible for the antiepileptic profile of the ketogenic diet. Patients who follow a ketogenic diet experience fewer seizures attacks. We do not know the long-term side effects of the ketogenic diet yet and it is impossible to make a definitive thesis. Scientists are working to prove the validity of ketogenic diet in drug-resistant epilepsy.

13 October 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
NDNatalia Domańska
Natalia Domańska
MBMałgorzata Bojarska
Małgorzata Bojarska
JBJulia Bogucka
Julia Bogucka
ABAnna Brzyska
Anna Brzyska
MKMichalina Kosowska
Michalina Kosowska
HPHalina Piecewicz-Szczęsna
Halina Piecewicz-Szczęsna
Introduction: Epilepsy is a chronic, non-infectious disease of the brain. Data shows that even 70 million people worldwide suffer from it and one-third of them fail to control it with anti-epileptic drugs. The gut microbiota has an impact on the course of the disease. The microbiota mediates between the gastrointestinal system and the central nervous system.Purpose: The aim of the work is to analyse how modification of the gut microbiota affects patients with drug-resistant epilepsy.Material and method: In December 2023, an extensive search was conducted and articles found in the Medline (PubMed) databases were selected by using the following keywords: drug-resistant epilepsy, gut microbiota, gut-brain axis, ketogenic diet, probiotics, faecal microbiota transplantation, to focus on recent developments and advancements in the field, the search was limited to articles published between 2017 and 2023.Conclusions: The intestinal microbiota in drug-resistant epilepsy (DRE) patients differs from that of healthy individuals or drug-sensitive epilepsy patients. Acknowledging the presence of the gut-brain axis and its impact on the central nervous system, we can view altering the flora as a potential therapeutic approach for DRE patients. The ways in which microbiota changes have been confirmed by research include: ketogenic diet, antibiotics, probiotics and fecal microbiota transplantation (FMT). Modifying the microbiota through these mentioned methods is all promising for treating DRE.

18 September 2025 in Pediatria i Medycyna Rodzinna
Verified
Journal Article
Open access
MMMagdalena Mosakowska
Magdalena Mosakowska
NPNatalia Aleksandra Pasierb
Natalia Aleksandra Pasierb
MKMichalina Faustyna Kosowska
Michalina Faustyna Kosowska
BRBarbara Teresa Rękas
Barbara Teresa Rękas
WDWiktoria Dzierzgowska
Wiktoria Dzierzgowska
Stanisław NiemczykStanisław Niemczyk
Stanisław Niemczyk
Objective: Vasculitis is an increasingly prevalent condition, often characterised by an insidious and multifaceted clinical course, which delays accurate diagnosis and treatment. Case Report: A 63-year-old male diagnosed with granulomatosis with polyangiitis (GPA), who demonstrated pulmonary disease progression after six months of remission-induction therapy with cyclophosphamide. Imaging studies revealed new cavitating infiltrates in the upper lobe of the left lung, along with numerous satellite nodules in both lungs. A thorough differential diagnosis ruled out infectious aetiologies. Conclusions: Despite extensive diagnostic efforts, including invasive procedures and positron emission tomography–computed tomography scanning, exclusion of malignancy remained challenging. Establishing an accurate diagnosis and excluding infectious or neoplastic diseases enables timely and appropriate treatment, which can be life-saving in patients with GPA. Delayed treatment increases the risk of GPA-related organ complications.

16 December 2024 in Quality in Sport
Verified
Journal Article
Open access
ARAneta Rostkowska
Aneta Rostkowska
SKSebastian Kupisiak
Sebastian Kupisiak
MDMalwina Draim
Malwina Draim
NPNatalia Pasierb
Natalia Pasierb
BRBarbara Rękas
Barbara Rękas
WDWiktoria Dzierzgowska
Wiktoria Dzierzgowska
Introduction and purpose Physical activity protects both physical and mental health. However, widespread physical inactivity is the leading risk factor for global mortality. Despite the promotion of healthy lifestyle, there has been no improvement in global levels of physical activity since 2001. This review aims to present the prevalence of physical activity and inactivity across Poland, the European Union (EU) and the world. This cross-national compilation can be used to create campaigns to raise social awareness around physical activity as well as to help health-care providers encourage patients to limit sedentary time. It provides a reliable comparison and indicates vulnerable points regarding the physical activity levels in our societies that should be monitored in further researches. Additionally, there is a summary of the most important health benefits associated with being more active and health risks arising from prolonged sitting time. Brief description of the state of knowledge World Health Organization (WHO) recommends adults to do at least 150 minutes of moderate-intensity, or 75 minutes of vigorous-intensity physical activity per week (or an equivalent combination of the two). Globally, more than 1 in 4 adults are insufficiently physically active. Summary If current trends in insufficient physical activity continue, the global target of a 15% relative reduction between 2018 and 2030 will not be met for adults. Investing in policies to promote active recreation and transport, creating affordable and safe spaces and conducting national and community-based campaigns play a key role in limitting sedentary behaviour and increasing physical activity.

30 December 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
JRJonatan Rataj
Jonatan Rataj
KHKamil Harenza
Kamil Harenza
KOKarolina Ollik
Karolina Ollik
MRMarlena Radzka
Marlena Radzka
MKMichalina Kosowska
Michalina Kosowska
MWMateusz Wiekiera
Mateusz Wiekiera
Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is a distinct subtype of extranodal marginal zone B-cell lymphoma strongly associated with Helicobacter pylori infection. This review presents an overview of current diagnostic and therapeutic strategies, highlighting recent developments in molecular diagnostics and evidence-based management. The diagnosis relies on histopathological evaluation supported by immunohistochemistry and molecular testing for characteristic translocations, particularly t(11;18)(q21;q21). First-line therapy remains H. pylori eradication, which induces complete and durable remission in most patients, including some who are H. pylori-negative. For those unresponsive to antibiotics, radiotherapy or rituximab-based immunotherapy achieves excellent local control and survival rates. Prognosis is generally favourable, with five-year overall survival exceeding 90%. However, complications such as gastrointestinal bleeding, perforation, and histologic transformation into diffuse large B-cell lymphoma (DLBCL) may occur. Early detection, accurate staging, and an individualized, risk-adapted therapeutic approach remain key factors influencing long-term outcomes. Advances in endoscopic imaging, molecular characterization, and targeted therapies continue to refine the management of gastric MALT lymphoma, supporting the trend toward more personalized treatment strategies and improved patient prognosis.